Windtree Therapeutics Plans $520 Million Raise, 99% for BNB, Secures $500M Equity Line, Uses Kraken Custody
Nasdaq-listed Windtree Therapeutics has announced plans to raise up to $520 million in new funding, with approximately 99% of the proceeds intended to purchase BNB for its corporate treasury...